FOLH1 and prostate carcinoma: The in vivo-targeteduptake and deep tumor uptake of those starPEGs were demonstrated usingPET imaging and organ biodistribution studies in a mouse model bearingdual prostate cancer xenografts of PSMA– PC3-Flu and PSMA+PC3-Pip (Figure 1).